The COPD CARE Study: Evaluating the Impact of a Virtual-First COPD Service on Major Cardiac and R… (NCT06379529) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
The COPD CARE Study: Evaluating the Impact of a Virtual-First COPD Service on Major Cardiac and Respiratory Events
1,050 participantsStarted 2026-01-01
Plain-language summary
A 12 month interventional study of up to 1,050 people with COPD to determine if the NuvoAir virtual-first clinical service leads to fewer moderate and severe COPD exacerbations and cardiac events, reduces healthcare utilization, and lowers the total cost of care compared to a control cohort that receives standard care only.
Who can participate
Age range30 Years – 100 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Twelve months of claims data in the health insurer or provider's database for baseline
* ICD10 code for COPD (including emphysema and chronic bronchitis) with a severe exacerbation of COPD in the previous 12 months (defined as ER visit or hospitalization related to COPD or severity score of 2 or 3)
* Cooperative, i.e., subject should be able to follow and understand instructions
* Access to a phone (smartphone, cell phone, or landline)
* Willingness to sign a medical release form for treating healthcare facilities
Exclusion Criteria:
* Does not have access to a a phone (smartphone, cell phone, or landline)
* Lack of cooperation, subject cannot follow and understand instructions
* Other serious medical illness that, in the opinion of the PI, would interfere with the patient's participation in the study or interpretation of their data (i.e., terminal illness, unstable psychiatric condition, etc.)
* Does not understand English